Ecolab delivered a mixed performance in the fourth quarter. Organic sales increased by 12%, and sector-wise growth was strong but the company failed to meet the revenue expectations of Wall Street. Industrial increased by 14% and Institutional and Specialty increased by 11%. Healthcare & Life Sciences resumed growth and delivered 7% organic growth. Pest Elimination also continued to be very strong, increasing by 10%. Volumes outside Europe remained stable year-over-year. Their net new business p ....
